| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |